Abstract: The present invention relates to a method for manufacturing an optical material comprising the following steps: i) mixing: A. at least one polymerizable component comprising at least one diallyl compound, B. at least one UV and/or HEV light-absorbing agent, C. at least one tetraazaporphyrin dye, D. at least one peroxydicarbonate esters as radical polymerization initiator, to obtain a polymerizable composition; ii) casting the polymerizable composition in at least one mould; iii) curing the polymerizable composition to obtain a solid polymerized molded element and extracting the solid polymerized molded element from the mould; iv) heat treating the solid polymerized molded element at a temperature within the range of from 50 degree C. to 150 degree C. to obtain the optical material.

Abstract: In some embodiments, the present invention provides respiratory syncytial virus (RSV) F proteins, polypeptides and protein complexes that comprise one or more cross-links to stabilize the protein, polypeptide or protein complex in its pre-fusion conformation. In some embodiments the present invention provides RSV F proteins, polypeptides and protein complexes comprising one or more mutations to facilitate such cross-linking. In some embodiments the present invention provides compositions comprising such proteins, polypeptides or protein complexes, including vaccine compositions, and methods of making and using the same.

Abstract: Modified FGF-21 polypeptides and uses thereof are provided.

Abstract: The present invention provides mutant RSV F molecules, such as those that can be, or are stabilized, in a pre-fusion conformation by the introduction of one or more DT cross-links. The present invention also provides methods of making such mutant RSV F molecules, compositions comprising such mutant RSV F molecules, and methods of use of such mutant RSV F molecules, for example in vaccination methods, therapeutic methods, and antibody production methods.

Abstract: The present invention provides mutant RSV F molecules, such as those that can be, or are stabilized, in a pre-fusion conformation by the introduction of one or more DT cross-links. The present invention also provides methods of making such mutant RSV F molecules, compositions comprising such mutant RSV F molecules, and methods of use of such mutant RSV F molecules, for example in vaccination methods, therapeutic methods, and antibody production methods.

Abstract: In some embodiments, the present invention provides respiratory syncytial virus (RSV) F proteins, polypeptides and protein complexes that comprise one or more cross-links to stabilize the protein, polypeptide or protein complex in its pre-fusion conformation. In some embodiments the present invention provides RSV F proteins, polypeptides and protein complexes comprising one or more mutations to facilitate such cross-linking. In some embodiments the present invention provides compositions comprising such proteins, polypeptides or protein complexes, including vaccine compositions, and methods of making and using the same.

Abstract: The present invention provides mutant RSV F molecules, such as those that can be, or are stabilized, in a pre-fusion conformation by the introduction of one or more DT cross-links. The present invention also provides methods of making such mutant RSV F molecules, compositions comprising such mutant RSV F molecules, and methods of use of such mutant RSV F molecules, for example in vaccination methods, therapeutic methods, and antibody production methods.

Abstract: A method is described for recording a video. The method comprises receiving one or more user content and then providing a 3D virtual world and a virtual camera having one or more parameters. The optimal 3D flight path of the virtual camera is then determined based on the user content and the virtual camera is then allowed to travel along the optimal 3D flight path and to record the video.

Abstract: A beverage dispensing machine designed for aircraft use has compact dimensions, is low-weight and satisfies the safety requirements and standards applicable in that sector. The beverage dispensing machine can dispense both large quantities of a beverage, such as 1.6 liters of American coffee or tea, inside a jug positioned inside an appropriate seat, and smaller quantities of hot water (typically 150 ml), which can be used to prepare beverages, via a nozzle situated on the outside thereof. In one embodiment, the beverage dispensing machine includes a bottom jug retention system having a locking lever hinged on spiral seats to keep the jug stationary during the dispensing of the beverage.

Abstract: Modified FGF-21 polypeptides and uses thereof are provided.

Abstract: Modified FGF-21 polypeptides and uses thereof are provided.

Abstract: The present invention provides mutant RSV F molecules, such as those that can be, or are stabilized, in a pre-fusion conformation by the introduction of one or more DT cross-links. The present invention also provides methods of making such mutant RSV F molecules, compositions comprising such mutant RSV F molecules, and methods of use of such mutant RSV F molecules, for example in vaccination methods, therapeutic methods, and antibody production methods.

Abstract: The present invention relates to a water heating system (part number lacubucci HF Aerospace AS0012480) for beverage dispensing machines. The heater has a double system: a pre-chamber, preferably of the spirally wound type, for pre-heating the water along a predefined path, and a chamber which is always full of water heated with resistors making direct contact with the water (or in some cases with a protection jacket) for maximizing the efficiency.

Abstract: A method is described for recording a video. The method comprises receiving one or more user content and then providing a 3D virtual world and a virtual camera having one or more parameters. The optimal 3D flight path of the virtual camera is then determined based on the user content and the virtual camera is then allowed to travel along the optimal 3D flight path and to record the video.

Abstract: Modified FGF-21 polypeptides and uses thereof are provided.

Abstract: In some embodiments, the present invention provides respiratory syncytial virus (RSV) F proteins, polypeptides and protein complexes that comprise one or more cross-links to stabilize the protein, polypeptide or protein complex in its pre-fusion conformation. In some embodiments the present invention provides RSV F proteins, polypeptides and protein complexes comprising one or more mutations to facilitate such cross-linking. In some embodiments the present invention provides compositions comprising such proteins, polypeptides or protein complexes, including vaccine compositions, and methods of making and using the same.

Abstract: Modified FGF-21 polypeptides and uses thereof are provided.

Abstract: A method is described for recording a video. The method comprises receiving one or more user content and then providing a 3D virtual world and a virtual camera having one or more parameters. The optimal 3D flight path of the virtual camera is then determined based on the user content and the virtual camera is then allowed to travel along the optimal 3D flight path and to record the video.

Abstract: In some embodiments, the present invention provides respiratory syncytial virus (RSV) F proteins, polypeptides and protein complexes that comprise one or more cross-links to stabilize the protein, polypeptide or protein complex in its pre-fusion conformation. In some embodiments the present invention provides RSV F proteins, polypeptides and protein complexes comprising one or more mutations to facilitate such cross-linking. In some embodiments the present invention provides compositions comprising such proteins, polypeptides or protein complexes, including vaccine compositions, and methods of making and using the same.

Abstract: Modified FGF-21 polypeptides and uses thereof are provided.